SEP 25, 2015 3:13 PM PDT

New Drug and Native Flora Combat C. difficile

WRITTEN BY: Kerry Evans
Clostridium difficile is a Gram positive, rod-shaped bacterium commonly found in the soil.  However, a small number of people, about 1 in 20, also house C. difficile in their guts. This usually isn’t a problem, but the bacteria can produce toxins that cause severe cases of colitis, diarrhea, and sometimes death. These infections typically occur in cases where the normal gut flora has been depleted by antibiotics, allowing C. difficile to “take over”.   

Since antibiotics often promote C. difficile infections, they aren’t much use in combating these bacteria. This has left researchers searching for other treatment options, and scientists at Stanford University School of Medicine have taken a unique approach.
 
C. difficile infection causes severe colitis and diarrhea.


Instead of searching for a way to kill C. difficile directly, Matthew Bogyo, Ph.D., used a small molecule called ebselen to disarm C. difficile toxins.  These toxins enter the cells lining the gut and induce an inflammatory response, resulting in colitis and diarrhea.  This proinflammatory response also prevents the normal flora from repopulating the gut.  

Bogyo and colleagues showed that ebselen had a direct effect on the activity of C. difficile toxins by incubating purified toxin with or without ebselen, and then injecting the mixtures into mice.  After three days, all of the mice injected with toxin alone died, while the mice injected with the ebselen and toxin mixture survived.  Bogyo then tested a more clinically relevant model of infection.  They first treated mice with antibiotics to mimic the conditions under which C. difficile infections occur.  Following antibiotic treatment, they infected mice with a highly virulent, drug-resistant strain of C. difficile, and treated them orally with ebselen.  The mice treated with ebselen survived the infection with little evidence of damage to the colon.  

Thus, ebselen both prevented damaging colitis and diarrhea, and allowed the normal flora to outcompete C. difficile.  What’s more, ebselen has already been tested in clinical trials to treat hearing loss in chemotherapy patients.  This means ebselen could be on the fast track to treating C. difficile infections.  

Ebselen isn’t the only unique approach to treating C. difficile. Fecal transplant, as explained in this video, has been highly successful in treating C. difficile infections.  

Sources: Science Daily, Science Translational Medicine, Wikipedia, Cleveland Clinic
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
SEP 27, 2020
Microbiology
New Insight Into An Old Bacterial Pathogen
SEP 27, 2020
New Insight Into An Old Bacterial Pathogen
There are many different strains of Escherichia coli bacteria, some of which live harmlessly in the human gut. But some ...
NOV 05, 2020
Clinical & Molecular DX
Digging DEEP into Metabolomic Space
NOV 05, 2020
Digging DEEP into Metabolomic Space
Metabolomics is an umbrella term encompassing lipidomics and the study of smaller polar metabolites.  As such, more ...
OCT 29, 2020
Cell & Molecular Biology
How Does the Immune System Handle the Microbiome?
OCT 29, 2020
How Does the Immune System Handle the Microbiome?
The human body plays host to trillions of microbes, and many of them live in our gastrointestinal tract; these microorga ...
NOV 06, 2020
Microbiology
Daily Aspirin Users Less Likely to Die From COVID-19
NOV 06, 2020
Daily Aspirin Users Less Likely to Die From COVID-19
Recent work has backed up research from earlier this year that suggested that aspirin might help prevent the worst cases ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 15, 2020
Microbiology
Monitoring a Virus in Real-Time as it Infects a Cell
NOV 15, 2020
Monitoring a Virus in Real-Time as it Infects a Cell
Hubrecht Institute researchers observe a virus as it invades a cell and competes with the host for control of the host c ...
Loading Comments...